CNS Pharmaceuticals, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $20.0M | $3.0M | $7.2M | $9.9M | $12.1M | $13.0M | $6.5M | $7.0M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $21.9M | $4.1M | $8.1M | $11.4M | $14.1M | $13.7M | $8.7M | $7.4M |
| Property, Plant & Equipment | $15.0K | $22.0K | $18.0K | $3.1K | $3.8K | $4.9K | $6.0K | $2.8K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $21.9M | $4.7M | $8.6M | $11.9M | $14.5M | $13.7M | $8.7M | $7.4M |
| Liabilities | ||||||||
| Accounts Payable | $3.7M | $4.4M | $3.8M | $1.9M | $1.3M | $2.6M | $2.2M | $4.0M |
| Total Current Liabilities | $3.7M | $4.6M | $4.1M | $2.0M | $1.4M | $2.8M | $2.5M | $4.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.7M | $4.6M | $4.1M | $2.0M | $1.4M | $2.8M | $2.5M | $4.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-107.8M | $-105.2M | $-100.3M | $-94.3M | $-91.1M | $-88.7M | $-84.4M | $-81.2M |
| Total Stockholders' Equity | $18.2M | $71.0K | $4.5M | $9.9M | $13.1M | $11.0M | $6.2M | $3.4M |